The nuclear power specialist is teaming up with a government agency on a pilot project.
This is the design and construction of a test facility for the production of radioisotopes.
News of a contract with a federal government agency was the inspiration for Oklo's (NYSE: OKLO) stock price rise on Wednesday. The next-generation nuclear power company's shares were cruising more than 3% higher in late-session trading that day.
Just before market open, Oklo announced it has signed a contract with the Department of Energy (DOE) to support the design and construction of a radioisotope pilot facility. The company did not mention where the plant will be located.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Image source: Getty Images.
Radioisotopes, short for radioactive isotopes, are unstable versions of chemical elements. They release energy in the form of radiation as they attempt to become stable, and are useful for products and applications in various fields, including healthcare and agriculture.
Oklo said its subsidiary, Atomic Alchemy, will use the facility to pilot the manufacturing of radioisotopes used for medical purposes. The company stated that many of these are currently produced outside the U.S.
Oklo did not disclose the financial particulars of its new deal with the DOE.
In its press release on the arrangement, Oklo quoted CEO Jacob DeWitte as saying that "By building and operating a pilot reactor, we generate the data and experience to streamline future commercial deployments, improve regulatory efficiency, and deliver long-term value."
Despite the numerous wins it's notched with the government's ambitions to bolster the domestic nuclear sector, Oklo is still a relatively young company that's still in the early phases of development. I'd view its new collaboration with the DOE positively, but to me the company still needs to prove it can both draw revenue and (at least eventually) reach profitability.
Before you buy stock in Oklo, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oklo wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $488,653!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,148,034!*
Now, it’s worth noting Stock Advisor’s total average return is 971% — a market-crushing outperformance compared to 196% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of January 7, 2026.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.